China Tracker - Details for Dehaier Medical Systems (DHRM)

 Dehaier Medical Systems
 Business Outlook

We believe there are significant opportunities to further penetrate the market and are confident that our innovative products, diversified marketing channels and network, growing customer database, and geographic expansion efforts collectively position Dehaier to accelerate growth among China's developing healthcare industry.

(Source: PR Newswire, 2011-08-15)

Given our efforts and accomplishments to date, attractive markets, financial growth and clear growth strategy, we are optimistic about Dehaier Medical's continued success throughout 2011 and well into the future. The overall healthcare market in China has grown significantly in recent years, with increasing awareness of health issues creating demand for improved infrastructure and higher levels of medical care in both urban and rural areas. We believe our cooperation with China Development Bank on rural medical care will generate more opportunities to grow our presence and build our reputation, particularly in the country's underdeveloped areas, where the need for products such as ours is greatest.

Additionally, last week, we announced a strategic cooperation agreement with Taiyo Nippon Sanso Shenwei (Shanghai) and Beijing Orient, two major medical gas providers in the global and Chinese market, to develop home oxygen therapy service in Beijing. We believe this cooperation will further solidify our market position in product and service offering. We expect these initiatives, coupled with the successful execution of our growth strategy, will drive continued financial and operational growth, and enhance value for shareholders.

(Source: PR Newswire, 2011-04-25)

"2010 was a record year for Dehaier. We achieved strong growth across both our branded and third party medical devices, as well as our homecare products businesses, while positioning the Company for success in 2011 and beyond. Key to our growth in 2010 was the continued advancement of our homecare products business, in which we achieved triple-digit gains for both the fourth quarter and full year. While the domestic market presents a compelling growth opportunity, international expansion is a critical element of our longer-term strategy and we are making meaningful progress in this regard, with several of our respiratory therapy homecare products currently pending regulatory approval in the United States and European Union. We believe that securing these approvals and rolling out our products in targeted international markets will provide another important catalyst for our business and help propel Dehaier to the next level of top- and bottom-line growth."

(Source: PR Newswire, 2011-03-07)
DHRM
Healthcare & Drugs
SCORE
4
READ: Score Cards Explained
SAFETY/RISK SCORE
HIGH RISK
DETAILS: Safety/Risk Model for DHRM
Current Price:  $1.69
F10k Day (2010-04-22): -86.57%$12.58
2010 Close: -71.55%$5.94
2011 Close: 19.01%$1.42
High (2012-04-23): -57.22%$3.95
Low (2012-09-20): 14.96%$1.47
Exchange: NCM
Market Capitalization: 7.88 mill
Total Shares: 4.66 mill
Float: n/a
Avg Volume: 5.20 k
Short Interest: 9.30 k
Short Ratio: 0.25%1.8 d
Last Quarter: 2011-03-31
Revenue (MRQ): 2.95 mill
Net Income (MRQ): 0.20 mill
Op. Cash Flow (MRQ): -2.11 mill
all financial data provided without warranty